Identification of early-stage liver fibrosis by modifications in the interstitial space diffusive microenvironment using fluorescent single-walled carbon nanotubes
Antony LeeiD, Apolline A. Simon, Adeline Boyreau, Nathalie Allain-Courtois, Benjamin Lambert, Jean-Philippe PradèreiD, Frédéric SalteliD, Laurent CognetiD
Abstract
During liver fibrosis, recurrent hepatic injuries lead to accumulation of collagen and other extracellular matrix components in the interstitial space, ultimately disrupting liver functions. Early stages of liver fibrosis may be reversible, but opportunities for diagnosis at these stages are currently limited. Here, we show that the alterations of the interstitial space associated with fibrosis can be probed by tracking individual fluorescent single-walled carbon nanotubes (SWCNTs) diffusing in that space. In a mouse model of early liver fibrosis, we find that nanotubes generally explore elongated areas, whose length decrease as the disease progresses even in regions where histopathological examination does not reveal fibrosis yet. Furthermore, this decrease in nanotube mobility is a purely geometrical effect, as the instantaneous nanotube diffusivity stays unmodified. This work establishes the promise of SWCNTs both for the diagnosis of liver fibrosis at an early stage, and for more in-depth studies of the biophysical effects of the disease.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- EVALUATION OF STAINING FOR FIBRONECTIN ISOFORMS IN LIVER DISEASES
Stefan Hamelmann, Juan C. Sarmiento, … Inaam A. Nakchbandi·bioRxiv·May 14, 2025
- The interplay between biomechanics and cell kinetics explains the spatial pattern in liver fibrosis
Jieling Zhao, Seddik Hammad, … Dirk Drasdo·bioRxiv·Jul 31, 2025
- A spatial map of human liver cirrhosis reveals the patho-architecture and gene signatures associated with cell state transitions during liver disease
Nigel L. Hammond, Syed Murtuza Baker, … Karen Piper Hanley·bioRxiv·Jun 28, 2023
- A multiscale analysis of liver lobule fibrosis and its impact on drug propagation and metabolism - a DLA approach
Vahid Rezania, Dennis Coombe, Jack A. Tuszyński·bioRxiv·Sep 3, 2026
- Tirzepatide reduces diet-induced senescence and NETosis-mediated liver fibrosis in mice
Feng Chen, QiQi Nam, … Siu Ling Wong·bioRxiv·May 27, 2025
- Utility of T1 mapping and T2 mapping for non-invasive assessment of liver fibrosis: preclinical results